BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38134319)

  • 21. Childhood mastocytosis.
    Torrelo A; Alvarez-Twose I; Escribano L
    Curr Opin Pediatr; 2012 Aug; 24(4):480-6. PubMed ID: 22790101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
    Merante S; Ferretti VV; Elena C; Brazzelli V; Zanotti R; Neri I; Magliacane D; Belloni Fortina A; Ingeborg F; Pastorello EA; Pieri L; Papayannidis C; Mauro M; Grifoni F; Minelli R; Guggiari E; Difonzo E; Bocchia M; Caroppo F; Di Nuzzo S; Elli EM; Rondoni M; Ciccocioppo R; Di Stefano M; Bossi G; Boveri E; Bonadonna P; Giona F; Valent P; Triggiani M
    Future Oncol; 2018 Nov; 14(26):2713-2723. PubMed ID: 30207489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic criteria and classification of mastocytosis: a consensus proposal.
    Valent P; Horny HP; Escribano L; Longley BJ; Li CY; Schwartz LB; Marone G; Nuñez R; Akin C; Sotlar K; Sperr WR; Wolff K; Brunning RD; Parwaresch RM; Austen KF; Lennert K; Metcalfe DD; Vardiman JW; Bennett JM
    Leuk Res; 2001 Jul; 25(7):603-25. PubMed ID: 11377686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When Mast Cells Run Amok: A Comprehensive Review and Case Study on Severe Neonatal Diffuse Cutaneous Mastocytosis.
    Olteanu EG; Bataneant M; Puiu M; Chirita-Emandi A
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mastocytosis.
    Abid A; Malone MA; Curci K
    Prim Care; 2016 Sep; 43(3):505-18. PubMed ID: 27545739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
    Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
    Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype and phenotype analysis of patients with pediatric cutaneous mastocytosis, especially wild-type KIT patients.
    Arase N; Wataya-Kaneda M; Murota H; Nakagawa Y; Yamaoka T; Itoi-Ochi S; Hirayasu K; Arase H; Fujimoto M; Katayama I
    J Dermatol; 2020 Apr; 47(4):426-429. PubMed ID: 32077120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis.
    Gebhard J; Horny HP; Kristensen T; Broesby-Olsen S; Zink A; Biedermann T; Brockow K
    J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1367-1375. PubMed ID: 35412687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.
    Alvarez-Twose I; Vañó-Galván S; Sánchez-Muñoz L; Morgado JM; Matito A; Torrelo A; Jaén P; Schwartz LB; Orfao A; Escribano L
    Allergy; 2012 Jun; 67(6):813-21. PubMed ID: 22458675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mastocytosis in the skin accompanied by pseudo-Kaposi's sarcoma.
    Vergara-de-la-Campa L; Torrado I; Recuero-Pradillo M; Torrelo A; Gironella M; Pardal E; Godoy AC; Matito A; Pérez-Hortet C; Mollejo M; Álvarez-Twöse I
    J Dermatol; 2021 May; 48(5):657-660. PubMed ID: 33684229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A CHILD CASE OF DIFFUSE CUTANEOUS MASTOCYTOSIS].
    Hoshino Y; Yoshida K; Numata T; Ito T; Egusa C; Maeda T; Sakai N; Harada K; Okubo Y
    Arerugi; 2022; 71(5):397-401. PubMed ID: 35831165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systemic mastocytosis].
    Niedoszytko M; Lange M; Chelminska M; Jaśkiewicz K; Piskosz A; Wasag B; Lewandowski K; Mital A; Renke J; Gruchała-Niedoszytko M; Woźniak M; Babińska A; Jassem E
    Pneumonol Alergol Pol; 2005; 73(3):239-44. PubMed ID: 16989160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intertriginous mastocytosis: a rare presentation of an uncommon disease.
    Simmons BJ; LeBlanc RE; Glass JS
    Int J Dermatol; 2019 Jul; 58(7):852-853. PubMed ID: 30079967
    [No Abstract]   [Full Text] [Related]  

  • 34. Mast Cell Burden in a Patient With Cutaneous Disease.
    Awosika O; Eleryan M; Rengifo-Pardo M; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1285-1287. PubMed ID: 29240865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric maculopapular cutaneous mastocytosis: Retrospective review of signs, symptoms, and associated conditions.
    Gurnee EA; Johansen ML; Phung TL; Guo EL; Fong A; Tollefson M; Nguyen H; Brandling-Bennett H; Moriarty N; Paller AS; Huynh TN; Lawley LP
    Pediatr Dermatol; 2021 Jan; 38(1):159-163. PubMed ID: 33068315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021.
    Lange M; Hartmann K; Carter MC; Siebenhaar F; Alvarez-Twose I; Torrado I; Brockow K; Renke J; Irga-Jaworska N; Plata-Nazar K; Ługowska-Umer H; Czarny J; Belloni Fortina A; Caroppo F; Nowicki RJ; Nedoszytko B; Niedoszytko M; Valent P
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cell disorders: Kids are not just little people.
    Rothe MJ; Grant-Kels JM; Makkar HS
    Clin Dermatol; 2016; 34(6):760-766. PubMed ID: 27968936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation.
    Zuluaga Toro T; Hsieh FH; Bodo J; Dong HY; Hsi ED
    Br J Haematol; 2007 Oct; 139(1):31-40. PubMed ID: 17662084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.